Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 VaccineA vaccine manufactured in plants and developed in CanadaQuebec City, London, February 24, 2022 – Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) toda.
A vaccine manufactured in plants and developed in Canada Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted
Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.
While speaking at the Food & Drug Law Institute's Enforcement, Litigation and Compliance Conference in December, Deputy Assistant Attorney General Arun Rao identified clinical trial fraud as one of four key areas.